Free Practice Questions for CMG Gastroenterología
Exam-style questions and explanations by OpenExamPrep.
Loading practice questions...
Explore More CONACEM Medical Specialty Board Certification Examinations (Mexico)
Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.
Key Facts: CMG Gastroenterología Exam
6 Feb 2027
Next examination date (CEAT Tlatelolco)
CMG convocatoria
3 Aug–26 Oct 2026
Registration window for the February 2027 exam
CMG convocatoria
MXN 5,000
Examination fee
CMG convocatoria
5 Sep 2026
Previous session
CMG convocatoria
5 years
Certification validity
CONACEM
The CMG certification exam is the CONACEM-recognized gastroenterology board exam in Mexico: an in-person written exam at CEAT Tlatelolco, next held on 6 February 2027, covering luminal, liver and pancreatobiliary medicine.
Sample CMG Gastroenterología Practice Questions
Try these sample questions to review concepts for the CMG Gastroenterología exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.
1A 44-year-old man presents with persistent heartburn and acid regurgitation. Upper endoscopy demonstrates mucosal breaks in the distal esophagus extending continuously between the tops of three mucosal folds, involving approximately 55% of the esophageal circumference. According to the Los Angeles Classification of erosive esophagitis, which grade should be assigned?
2A 38-year-old woman has refractory retrosternal burning despite twice-daily omeprazole therapy. Upper endoscopy reveals no mucosal breaks or Barrett mucosa. Ambulatory 24-hour pH-impedance monitoring off proton pump inhibitors is scheduled. According to the Lyon 2.0 consensus criteria, which physiologic metric provides conclusive objective evidence of pathologic gastroesophageal reflux?
3A 56-year-old man undergoes surveillance endoscopy for Barrett esophagus. High-definition endoscopy reveals a circumferential segment of columnar-lined esophagus measuring 3 cm with a maximal longitudinal extent of 5 cm (Prague C3M5). According to international consensus and the Seattle biopsy protocol, how should surveillance mucosal biopsies be obtained?
4A 62-year-old man with a 4 cm segment of Barrett esophagus undergoes surveillance endoscopy. Biopsies confirm high-grade dysplasia (HGD) verified by an expert gastrointestinal pathologist. Careful inspection with high-definition chromoendoscopy shows flat mucosa without discrete nodules or depressed lesions. Which therapeutic intervention is currently recommended as first-line management?
5A 34-year-old woman presents with progressive solid and liquid dysphagia, regurgitation of undigested food, and an 8 kg weight loss. High-resolution manometry (HRM) demonstrates an elevated median integrated relaxation pressure (IRP) of 28 mmHg (upper limit of normal 15 mmHg), 100% failed peristalsis, and panesophageal pressurization in 40% of test swallows. According to the Chicago Classification v4.0, which diagnosis is established?
6A 48-year-old man is diagnosed with Type III (spastic) achalasia characterized by an elevated IRP and premature, spastic contractions involving the distal 10 cm of the tubular esophagus on high-resolution manometry. Which intervention provides the highest clinical success rate specifically for this achalasia subtype?
7A 26-year-old atopic man presents to the emergency department with acute meat impaction requiring urgent endoscopic bolus extraction. Endoscopy demonstrates circular mucosal rings (trachealization), linear furrows, and white exudative plaques. Esophageal mucosal biopsies are obtained. Which histological finding confirms the diagnosis of eosinophilic esophagitis (EoE)?
8A 52-year-old man develops excruciating lower chest and epigastric pain following repeated episodes of forceful retching and vomiting after an alcoholic binge. Physical examination reveals tachypnea, diaphoresis, and subcutaneous crepitus palpable along the suprasternal notch. Which clinical entity and classic triad are demonstrated?
9A 71-year-old man presents with progressive cervical dysphagia, foul-smelling halitosis, nocturnal regurgitation of undigested food, and recurrent aspiration pneumonia. A barium swallow reveals a 4 cm posterior saccular outpouching arising just proximal to the cricopharyngeal muscle. Through which anatomical area of potential weakness does this diverticulum herniate?
10A 45-year-old woman in Mexico City is diagnosed with an active Helicobacter pylori-associated duodenal ulcer. Assume that local clarithromycin resistance exceeds 15% and metronidazole resistance is high, and that susceptibility testing is not available. According to the Maastricht VI/Florence consensus, which regimen is the preferred first-line empiric eradication therapy?
About the CMG Gastroenterología Exam
Independent CMG gastroenterology certification study practice by OpenExamPrep. The Consejo Mexicano de Gastroenterología, A.C., recognized by CONACEM, certifies gastroenterologists through an in-person written exam at CEAT Tlatelolco, Mexico City, with registration through SIGME. After the 5 September 2026 session, the next exam is scheduled for 6 February 2027 (registration 3 August–26 October 2026, fee MXN 5,000). The official exam is in Spanish; this bank is an independent English-language MCQ study adaptation built from current international guidelines. It is not an official translation or simulation.
Exam sponsor: Consejo Mexicano de Gastroenterología, A.C. (CMG). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.
Assessment
In-person written multiple-choice examination at CEAT (UNAM) Tlatelolco in Mexico City. The council does not publish the item count, duration or a percentage pass mark. This bank groups practice into esophagogastric disease and GI bleeding, hepatology, intestinal disease and motility, pancreatobiliary disease, and GI oncology and nutrition (an OpenExamPrep study grouping, not an official blueprint).
Time Limit
not-published
Passing Score
not-published
Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.
Official sources
- Consejo Mexicano de Gastroenterología, A.C. — Portal Oficial · Source checked 2026-09-29Official website of the CMG with convocatoria announcements, prerequisites, and certification guidelines
- CMG — Convocatorias para el Examen de Certificación · Source checked 2026-09-29Official calls: the 5 September 2026 session at CEAT Tlatelolco and the next session on 6 February 2027 (registration 3 August–26 October 2026), fee MXN 5,000
- Comité Normativo Nacional de Consejos de Especialidades Médicas (CONACEM) · Source checked 2026-09-29Regulatory body under Mexican General Health Law granting idoneidad to the Consejo Mexicano de Gastroenterología
Our practice resources: topics covered
We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.
Enfermedades Esofagogástricas y Hemorragia Digestiva
Gastroesophageal reflux disease (Montreal criteria, Lyon 2.0 consensus, ambulatory pH-impedance monitoring), Barrett esophagus surveillance and ablation criteria, motor disorders including achalasia (Chicago v4.0 manometry classification, Heller myotomy, POEM, pneumatic dilation), peptic ulcer disease and Helicobacter pylori quadruple bismuth eradication regimens, and acute upper GI bleeding (Forrest classification, endoscopic hemostatic modalities, IV PPI infusion, erythromycin prokinetics)
Hepatología y Cirrosis Hepática
Viral hepatitis B and C serologies and direct-acting antiviral (DAA) therapy, autoimmune hepatitis (IAHG scoring, steroids/azathioprine), primary biliary cholangitis (anti-mitochondrial antibodies, UDCA, second-line PPAR agonists), MASLD/MASH non-invasive fibrosis staging (FIB-4, transient elastography), portal hypertension and variceal hemorrhage prophylaxis (non-selective beta-blockers, band ligation), ascites evaluation (SAAG >= 1.1 g/dL), spontaneous bacterial peritonitis (PMN >= 250/mm3, cefotaxime, IV albumin), hepatorenal syndrome (terlipressin/albumin criteria), hepatic encephalopathy (lactulose, rifaximin), and hepatocellular carcinoma surveillance and staging (LI-RADS, Milan criteria)
Enfermedades Intestinales, Malabsorción y Motilidad
Inflammatory bowel disease differentiation (ulcerative colitis vs Crohn disease, Montreal phenotypic classification, endoscopic Mayo score, SES-CD, biologic therapies including anti-TNF, anti-integrin alpha4beta7 vedolizumab, and IL-12/23 inhibitors), celiac disease serological and histological diagnosis (anti-tTG IgA, Marsh criteria), microscopic colitis (collagenous and lymphocytic), irritable bowel syndrome (Rome IV diagnostic criteria, secretagogues, antispasmodics), and Clostridioides difficile infection management (oral vancomycin, fidaxomicin, recurrent disease strategies)
Patología Pancreatobiliar
Acute pancreatitis diagnosis and classification (revised Atlanta classification, mild vs moderately severe vs severe, BISAP scoring, fluid resuscitation, enteral nutrition, and infected necrosis step-up catheter drainage approach), chronic pancreatitis diagnosis (pancreatic exocrine insufficiency, fecal elastase-1, enzyme replacement therapy), choledocholithiasis and acute ascending cholangitis (Tokyo Guidelines 2018 criteria, urgent ERCP decompression), autoimmune pancreatitis (type 1 IgG4-related vs type 2, HISORt criteria), and pancreatic cystic lesions (branch-duct IPMN, mucinous cystic neoplasms, Fukuoka/Sendai surveillance criteria)
Oncología Digestiva y Nutrición Clínica
Gastric adenocarcinoma risk factors (H. pylori, atrophic gastritis, intestinal metaplasia, Operative Link for Gastritis Assessment [OLGA/OLGIM]), esophageal carcinoma staging, colorectal cancer screening and surveillance post-polypectomy guidelines (USMSTF/ESGE risk stratification), gastrointestinal stromal tumors (GIST, c-KIT mutation, imatinib), neuroendocrine tumors (chromogranin A, octreoscan/Ga-68 DOTATATE), short bowel syndrome pathophysiology and GLP-2 analog therapy (teduglutide), and total enteral/parenteral nutrition complications (refeeding syndrome)
Preparing for the CMG Gastroenterología Exam
What You Need to Know
- Passing score: not-published
- Assessment: In-person written multiple-choice examination at CEAT (UNAM) Tlatelolco in Mexico City. The council does not publish the item count, duration or a percentage pass mark. This bank groups practice into esophagogastric disease and GI bleeding, hepatology, intestinal disease and motility, pancreatobiliary disease, and GI oncology and nutrition (an OpenExamPrep study grouping, not an official blueprint).
- Time limit: not-published
- Exam / certification fees: MXN 5,000 Official sources
Using Our Practice Resources
- Work through all 100 available questions
- Review every answer and explanation
- Track weak areas and revisit them
- Use our AI tutor for tough concepts
CMG Gastroenterología: Suggested Study Strategy
Frequently Asked Questions
What is the CMG gastroenterology certification exam?
The Examen de Certificación en Gastroenterología is administered by the Consejo Mexicano de Gastroenterología, A.C. (CMG), the council recognized by CONACEM for the specialty. Certification is valid for 5 years and is renewed through recertification.
When and where is the next CMG certification examination?
The 2026 session was held in person on Saturday 5 September 2026 at CEAT Tlatelolco in Mexico City. The next session is scheduled for 6 February 2027 at CEAT, with registration through SIGME from 3 August to 26 October 2026.
What is the registration fee and passing standard for the CMG exam?
The examination fee is MXN 5,000. The CMG does not publish a fixed percentage pass mark, the item count or the exam duration in advance.
What curriculum and clinical topics are evaluated on the exam?
The CMG does not publish a weighted blueprint. Practice here covers esophagogastric disease (GERD, achalasia, Barrett esophagus, ulcer disease, GI bleeding), hepatology and cirrhosis complications, intestinal disorders (IBD, celiac disease, IBS, C. difficile), pancreatobiliary disease, and GI oncology and clinical nutrition, based on current international guidelines.
Why is this OpenExamPrep question bank provided in English?
The official CMG examination is administered in Spanish. This bank is an independent English-language MCQ study adaptation for reviewing diagnostic criteria and guideline-based management. It is not an official translation or simulation.